Serum bone gamma-carboxyglutamic acid-containing (Gla) protein (sBGP), a sensitive and specific marker of bone turnover, was measured in 25 patients with primary hyperparathyroidism and in 24 patients with bone metastases with or without hypercalcemia. Despite similar levels of hypercalcemia, sBGP was increased in primary hyperparathyroidism (14.2 +/- 9.6 ng/ml, P less than 0.001), was decreased in malignant hypercalcemia (3.1 +/- 2.8 ng/ml, P less than 0.001), and was normal in patients with bone metastases without hypercalcemia (6.6 +/- 2.7 ng/ml). In primary hyperparathyroidism, sBGP was correlated with serum immuno-reactive parathyroid hormone (r = 0.90), calcium (r = 0.73), and with the adenoma weight (r = 0.79). After parathyroidectomy, sBGP slowly returned to normal values within 2-6 mo, suggesting that sBGP reflects increased bone turnover rather than a direct effect of parathyroid hormone on BGP synthesis at the cell level. An iliac crest biopsy was performed in 11 patients with primary hyperparathyroidism and in 9 cancer patients in a noninvaded area. sBGP was significantly correlated with all parameters reflecting bone formation but not with bone resorption. Patients with bone metastases were analyzed according to the presence or the absence of hypercalcemia. In contrast to normocalcemic patients who had normal sBGP, hypercalcemic patients had decreased sBGP (P less than 0.001) and a lower bone formation at the cellular level (P less than 0.05). Thus, biochemical and histological data suggest that an unknown humoral factor might be responsible for this uncoupling between increased resorption and decreased formation. This uncoupling, rather than local release of calcium by the metastatic process, might be responsible for hypercalcemia in patients with bone metastases.
P D Delmas, B Demiaux, L Malaval, M C Chapuy, C Edouard, P J Meunier
Title and authors | Publication | Year |
---|---|---|
Influence of N- and/or P-restriction on bone metabolism in young goats
Zillinger LS, Liesegang A, Hustedt K, Schnepel N, Sauerwein H, Schmicke M, Schwennen C, Muscher-Banse AS |
The British Journal of Nutrition | 2024 |
Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation.
Ladang A, Rauch F, Delvin E, Cavalier E |
Calcified Tissue International | 2022 |
12 Weeks of Physical Exercise Attenuates Oxidative Stress, Improves Functional Tests Performance, and Reduces Fall Risk in Elderly Women Independently on Serum 25(OH)D Concentration.
Rodziewicz-Flis EA, Kawa M, Flis DJ, Szaro-Truchan M, Skrobot WR, Kaczor JJ |
Frontiers in physiology | 2022 |
Bone Phenotyping Approaches in Human, Mice and Zebrafish – Expert Overview of the EU Cost Action GEMSTONE (“GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork”)
I Foessl, JH Bassett, Å Bjørnerem, B Busse, Â Calado, P Chavassieux, M Christou, E Douni, IA Fiedler, JE Fonseca, E Hassler, W Högler, E Kague, D Karasik, P Khashayar, BL Langdahl, VD Leitch, P Lopes, G Markozannes, FE McGuigan, C Medina-Gomez, E Ntzani, L Oei, C Ohlsson, P Szulc, JH Tobias, K Trajanoska, Ş Tuzun, A Valjevac, B van Rietbergen, GR Williams, T Zekic, F Rivadeneira, B Obermayer-Pietsch |
Frontiers in Endocrinology | 2021 |
Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice
H Aljohani, JP Stains, S Majumdar, D Srinivasan, L Senbanjo, MA Chellaiah |
Bone Research | 2021 |
Functionalization of a clustered TiO2 nanotubular surface with platelet derived growth factor-BB covalent modification enhances osteogenic differentiation of bone marrow mesenchymal stem cells
Q Ma, N Jiang, S Liang, F Chen, L Fang, X Wang, J Wang, L Chen |
Biomaterials | 2020 |
Biochemical bone turnover markers in hormonal disorders in adults: a narrative review
P Szulc |
Journal of Endocrinological Investigation | 2020 |
Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
AB Shupp, AD Kolb, D Mukhopadhyay, KM Bussard |
Cancers | 2018 |
Laboratory aspects and clinical utility of bone turnover markers
Harjit Pal Bhattoa |
EJIFCC | 2018 |
Changes of Bone Turnover Markers in Long Bone Nonunions Treated with a Regenerative Approach
D Granchi, E Gómez-Barrena, M Rojewski, P Rosset, P Layrolle, B Spazzoli, DM Donati, G Ciapetti |
Stem Cells International | 2017 |
Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease
MB Greenblatt, JN Tsai, MN Wein |
Clinical chemistry | 2016 |
Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?
P Chavassieux, N Portero-Muzy, JP Roux, P Garnero, R Chapurlat |
The Journal of clinical endocrinology and metabolism | 2015 |
Evaluation of in vitro Efficacy of Vitamin D3 on the Osteogenic Differentiation and Mineralization Capabilities of Fetal and Adult Osteoblasts of Rabbit Reflects Therapeutic Potential
R Pathak, A ., P Tamilmahan, K Dhama, N Sharma |
International Journal of Pharmacology | 2014 |
Human adipose tissue-derived stromal cell therapy prevents bone loss in ovariectomized nude mouse
SW Cho, HJ Sun, JY Yang, JY Jung, HJ Choi, JH An, SW Kim, SY Kim, KJ Park, CS Shin |
Tissue Engineering Part A | 2012 |
The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis
P Szulc |
Clinical Biochemistry | 2012 |
The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy
S Alonso, E Ferrero, M Donat, G Martínez, C Vargas, M Hidalgo, E Moreno |
Journal of Endocrinological Investigation | 2011 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Potential utility of high preoperative levels of serum type I collagen markers in postmenopausal women with primary hyperparathyroidism with respect to their short-term variations after parathyroidectomy
P Boudou, F Ibrahim, C Cormier, E Sarfati, JC Souberbielle |
Journal of Bone and Mineral Metabolism | 2009 |
Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer
YC Chen, DM Sosnoski, UH Gandhi, LJ Novinger, KS Prabhu, AM Mastro |
Carcinogenesis | 2009 |
Osteocalcin Attenuates T3- and Increases Vitamin D3-Induced Expression of MMP-13 in Mouse Osteoblasts
F VARGA, M RUMPLER, S SPITZER, H KARLIC, K KLAUSHOFER |
Endocrine Journal | 2009 |
Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis
P Szulc, PD Delmas |
Osteoporosis International | 2008 |
Bone turnover markers: An appreciation of the contribution of Dr. P.D. Delmas
R Eastell |
Bone | 2008 |
The bone microenvironment in metastasis; what is special about bone?
KM Bussard, CV Gay, AM Mastro |
Cancer and Metastasis Reviews | 2007 |
Posttransplant bone disease
N Agrawal, MA Josephson |
Transplantation Reviews | 2007 |
The testosterone mimetic properties of icariin
ZB Zhang, QT Yang |
Asian Journal of Andrology | 2006 |
Dynamics of Bone and Cartilage Metabolism
JE Mulder, CA Kulak, E Shane |
Dynamics of Bone and Cartilage Metabolism | 2006 |
Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K
RR Mercer, AM Mastro |
Experimental Cell Research | 2005 |
Bone mineral density and bone turnover markers in children with chronic renal failure
AM Bakr |
Pediatric Nephrology | 2004 |
Metastatic breast cancer cells suppress osteoblast adhesion and differentiation
RR Mercer, C Miyasaka, AM Mastro |
Clinical & Experimental Metastasis | 2004 |
Matrix molecules and growth factors as indicators of periodontal disease activity
WV Giannobile, KF Al-Shammari, DP Sarment |
Periodontology 2000 | 2003 |
Markers of Bone Remodeling in Metastatic Bone Disease
B Fohr, CR Dunstan, MJ Seibel |
The Journal of clinical endocrinology and metabolism | 2003 |
Pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen in uremic hyperparathyroidism
T Hatada, H Ikeda, Y Fujiwara, K Yoh, T Yamamura |
Nephrology | 2002 |
Acoustical Imaging
H Lee |
2002 | |
The Parathyroids
SJ Marx |
The Parathyroids | 2001 |
Vitamin K supplementation reduces serum concentrations of under-γ-carboxylated osteocalcin in healthy young and elderly adults
NC Binkley, DC Krueger, JA Engelke, AL Foley, JW Suttie |
The American journal of clinical nutrition | 2000 |
Measurement of Osteocalcin
AJ Lee, S Hodges, R Eastell |
Annals of Clinical Biochemistry | 2000 |
Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study
H Engler, RE Oettli, WF Riesen |
Clinica Chimica Acta | 1999 |
Bone Turnover in Preterm Infants
KE Naylor, R Eastell, KE Shattuck, AC Alfrey, GL Klein |
Pediatric Research | 1999 |
Calciotropic Hormones and Bone Markers in the Elderly
JC Gallagher, HK Kinyamu, SE Fowler, B Dawson-Hughes, GP Dalsky, SS Sherman |
Journal of Bone and Mineral Research | 1998 |
BIOCHEMICAL MARKERS OF BONE TURNOVER
P Garnero, PD Delmas |
Endocrinology and metabolism clinics of North America | 1998 |
Cancer and Bone*
TA Guise, GR Mundy |
Endocrine reviews | 1998 |
Osteoporosis
DL Glaser, FS Kaplan |
Spine | 1997 |
Osteocalcin (BGP), Gene Expression, and Protein Production by Marrow Stromal Adipocytes
D Benayahu, A Shamay, S Wientroub |
Biochemical and Biophysical Research Communications | 1997 |
4 Bone markers
P Garnero, PD Delmas |
Baillière's Clinical Rheumatology | 1997 |
Hypercalcemia of Malignancy
GR MD, TA MD |
The American Journal of Medicine | 1997 |
New developments in biochemical markers for osteoporosis
P Garnero, PD Delmas |
Calcified Tissue International | 1996 |
Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma
M Laroche, M Attal, C Dromer |
Clinical Rheumatology | 1996 |
Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment
J Vinholes, R Coleman, R Eastell |
Cancer Treatment Reviews | 1996 |
Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole
G Lupoli, V Nuzzo, CD Carlo, P Affmito, M Vollery, G Vitale, E Cascone, F Arlotta, C Nappi |
Gynecological Endocrinology | 1996 |
A comparison of the effects of parathyroid hormone and parathyroid hormone-related protein on osteocalcin in the rat
CM Gundberg, MI Fawzi, ME Clough, MS Calvo |
Journal of Bone and Mineral Research | 1995 |
Osteocalcin in congenital adrenal hyperplasia
L Lisá, M Neradilová, N Tomášová, M Soutorová, J Zimák |
Bone | 1995 |
Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized study
SJ Wimalawansa |
The American Journal of Medicine | 1995 |
Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism
M Katagiri, T Ohtawa, M Fukunaga, T Harada |
Surgery Today | 1995 |
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques
VK Singh, ME Gnegy, SP Gupta, R Leurs, RC Vollinga, H Timmerman, RW Fuller, NC Cohen, V Tschinke, EJ Benaksas, ED Murray, WJ Wechter, I Dwivedy, S Ray, E Jucker |
1995 | |
Systemic bone growth factors in light breed mares and their foals
MJ Davicco, Y Faulconnier, V Coxam, H Dubroeucq, W Martin-Rosset, JP Barlet |
Archives Of Physiology And Biochemistry | 1994 |
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer
T Taube, I Elomaa, C Blomqvist, MN Beneton, JA Kanis |
Bone | 1994 |
Metastatic Bone Disease
IJ Diel, M Kaufmann, G Bastert |
1994 | |
Biochemical markers of bone turnover
PD Delmas |
Journal of Bone and Mineral Research | 1993 |
Biochemical markers of bone turnover in women with surgically treated carcinoma of the breast
F Li, PI Pitt, R Sherwood, J Barrettt, J Houghton, V Parsons, C Moniz |
European Journal of Clinical Investigation | 1993 |
Serum bone Gla protein as a marker of bone turnover in acromegaly
M Marazuela, B Astigarraga, MJ Tabuenca, J Estrada, F Marn, T Lucas |
Calcified Tissue International | 1993 |
Physiology and Pharmacology of Bone
GR Mundy, TJ Martin |
1993 | |
Biochemical markers of bone turnover for the clinical investigation of osteoporosis
PD Delmas |
Osteoporosis International | 1993 |
Osteologie aktuell VII
HJ Pesch, H Stöß, B Kummer |
1993 | |
Effect of a single infusion of alendronate in malignant hypercalcaemia: Dose dependency and comparison with clodronate
R Rizzoli, B Buchs, JP Bonjour |
International Journal of Cancer | 1992 |
Serum intact molecule of bone Gla-protein in patients with abnormal bone and calcium metabolism
K Nakatsuka, T Miki, S Shoji, Y Nishizawa, H Morii |
Journal of Bone and Mineral Metabolism | 1992 |
Effect of fluoride on bone and bone cells in ovariectomized rats
D Modrowski, L Miravet, M Feuga, F Bannié, PJ Marie |
Journal of Bone and Mineral Research | 1992 |
Insulin-like growth factor-II increases plasma osteocalcin concentration in newborn lambs
V Coxam, MJ Davicco, P Pastoureau, PD Delmas, JP Barlet |
Bone and Mineral | 1992 |
Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis
N Kojima, S Sakata, S Nakamura, K Nagai, H Takuno, T Ogawa, I Matsui, H Sarui, K Miura |
Journal of Endocrinological Investigation | 1992 |
Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment
L Mosekilde, EF Eriksen, P Charles |
Critical Reviews in Oncology/Hematology | 1991 |
Serum osteocalcin levels in primary hyperparathyroidism
P Pietschmann, B Niederle, A Anvari, W Woloszczuk |
Klinische Wochenschrift | 1991 |
Serum markers of bone formation in parenteral nutrition patients
AM Parfitt |
Calcified Tissue International | 1991 |
Serum osteocalcin (Bone Gla-Protein), an index of bone growth in lambs. Comparison with age-related histomorphometric changes
P Pastoureau, PJ Meunier, PD Delmas |
Bone | 1991 |
3 What do we know about biochemical bone markers?
PD Delmas |
Baillière's Clinical Obstetrics and Gynaecology | 1991 |
Abnormal serum bone gla protein levels in multiple myeloma: Crucial role of bone formation and prognostic implications
R Bataille, PD Delmas, D Chappard, J Sany |
Cancer | 1990 |
Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal women
ME Arlot, PD Delmas, D Chappard, PJ Meunier |
Osteoporosis International | 1990 |
Serum markers of bone formation in parenteral nutrition patients
EW Lipkin, SM Ott, GL Klein, LJ Deftos |
Calcified Tissue International | 1990 |
Bone gla protein (osteocalcin) assay standardization report
PD Delmas, C Christiansen, KG Mann, PA Price |
Journal of Bone and Mineral Research | 1990 |
Parathyroid hormone-related protein and hypercalcemia in pancreatic neuro-endocrine tumors
R Rizzoli, AP Sappino, JP Bonjour |
International Journal of Cancer | 1990 |
Clinical Utility of Serum Osteocalcin
HA Fritsche |
Cancer Investigation | 1990 |
Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase
C Vermeer |
Biochemical Journal | 1990 |
Hypercalcemia in malignancy
GJ Strewler, RA Nissenson |
The Western journal of medicine | 1990 |
Normal car☐ylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone
B Merle, PD Delmas |
Bone and Mineral | 1990 |
The response of circulating parameters of bone mineral metabolism to ethanol- and EDTA-induced hypocalcemia in the rat
S Thomas, C Movsowitz, S Epstein, P Jowell, F Ismail |
Bone and Mineral | 1990 |
New Techniques in Metabolic Bone Disease
R Lindsay |
New Techniques in Metabolic Bone Disease | 1990 |
Biochemical Markers of Bone Turnover for the Clinical Assessment of Metabolic Bone Disease
PD Delmas |
Endocrinology and metabolism clinics of North America | 1990 |
Serum Bone Gla-Protein in Hypercalcemia of Primary Hyperparathyroidism and Malignancy
RD Virgilio, MD Lazzari, GD Rin, P Legovini, G Foscolo, I Roiter, N Conte |
TUMORI | 1990 |
Bone gla: Protein in blood derived directly from human bone tissue
KJ Obrant, U Bengnér, PD Delmas |
Calcified Tissue International | 1989 |
Bone-derived proteins
S Epstein |
Trends in Endocrinology & Metabolism | 1989 |
Clinical Impact of Bone and Connective Tissue Markers
PD Delmas |
Clinical Impact of Bone and Connective Tissue Markers | 1989 |
Histomorphometric Analysis of Bone in Metabolic Bone Disease
EF Eriksen, T Steiniche, L Mosekilde, F Meisen |
Endocrinology and metabolism clinics of North America | 1989 |
Etiologies and Therapy of Hypercalcemia
JP Bilezikian |
Endocrinology and metabolism clinics of North America | 1989 |
Serum osteocalcin levels in breast cancer patients
P Pietschmann, C Zielinski, W Woloszczuk |
Journal of Cancer Research and Clinical Oncology | 1989 |
Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism
K Mizunashi, Y Furukawa, R Miura, S Yumita, HE Sohn, K Yoshinaga |
Journal of Clinical Investigation | 1988 |
Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy
PS Jowell, S Epstein, F Ismail, B Hollis, IR Schwartz |
Calcified Tissue International | 1988 |
Osteocalcin and bone morphometric parameters in adults without bone disease
M Garcia-Carrasco, M Gruson, MC Vernejoul, M Denne, L Miravet |
Calcified Tissue International | 1988 |
PTH mRNA transcription analysis in infantile tumors associated with hypercalcemia
MF Rousseau-Merck, C Nezelof, YD Keyzer, A Bourdeau, G Cournot, F Mercier |
Cancer | 1988 |
Can serum osteocalcin levels predict bone turnover in patients with osteoporosis?
T Tsunenari, M Takenaka, M Fukase, T Fujita |
Journal of Bone and Mineral Metabolism | 1988 |
Effects of moderate physical training on prednisone-induced protein wasting: A study of whole-body and bone protein metabolism
DR Garrel, PD Delmas, C Welsh, MJ Arnaud, SE Hamilton, MM Pugeat |
Metabolism | 1988 |
Hypercalcemia
JP Bilezikian |
Disease-a-Month | 1988 |
Osteocalcin: a potential marker of metastatic bone disease and response to treatment
RE Coleman, G Mashiter, I Fogelman, KD Whitaker, M Caleffi, DW Moss, RD Rubens |
European Journal of Cancer and Clinical Oncology | 1988 |
Cyclic AMP-mediated stabilization of osteocalcin mRNA in rat osteoblast-like cells treated with parathyroid hormone
M Noda, K Yoon, GA Rodan |
The Journal of biological chemistry | 1988 |
Osteocalcin and bone morphometric parameters in adults without bone disease
M Garcia-Carrasco, M Gruson, MC de Vernejoul, M annick Denne, L Miravet |
Calcified Tissue International | 1988 |
Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly
C de la Piedra, E Carbó, J Larrañaga, N Castro, C Horcajada, A Rapado, JL Pombo |
Calcified Tissue International | 1988 |
Serum bone gla-protein in multiple myeloma
R Bataille, P Delmas, J Sany |
Cancer | 1987 |
Evaluation of mineral metabolism and bone turnover in osteoporotic females treated with phosphorus and salmon calcitonin
FP Cantatore, M Carrozzo, DM Magli, M D'Amore, V Pipitone |
Clinical Rheumatology | 1987 |
Radioimmunoassay for osteonectin. Concentrations in bone, nonmineralized tissues, and blood
L Malaval, B Fournier, PD Delmas |
Journal of Bone and Mineral Research | 1987 |
Serum osteocalcin (BGP) in tumor-associated hypercalcemia
JJ Body, A Cleeren, M Pot, A Borkowski |
Journal of Bone and Mineral Research | 1986 |
OSTEOPOROSIS
AM Cooks |
The Lancet | 1955 |